Cargando…

A Novel pacing option in patients with endomyocardial fibrosis: A case series

Endomyocardial fibrosis (EMF) is characterized by fibrous tissue deposition on the endocardial surface leading to impaired filling of one or both ventricles, resulting in either right or left heart failure or both. Although Sinus node dysfunction and tachyarrhythmia - atrial fibrillation, ventricula...

Descripción completa

Detalles Bibliográficos
Autores principales: Sundaram, Chandrasekar, Kartik S, Viswanatha, Namboodiri, Narayanan, Ajitkumar, Valaparambil K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8414184/
https://www.ncbi.nlm.nih.gov/pubmed/34044159
http://dx.doi.org/10.1016/j.ipej.2021.05.007
_version_ 1783747760760029184
author Sundaram, Chandrasekar
Kartik S, Viswanatha
Namboodiri, Narayanan
Ajitkumar, Valaparambil K
author_facet Sundaram, Chandrasekar
Kartik S, Viswanatha
Namboodiri, Narayanan
Ajitkumar, Valaparambil K
author_sort Sundaram, Chandrasekar
collection PubMed
description Endomyocardial fibrosis (EMF) is characterized by fibrous tissue deposition on the endocardial surface leading to impaired filling of one or both ventricles, resulting in either right or left heart failure or both. Although Sinus node dysfunction and tachyarrhythmia - atrial fibrillation, ventricular tachycardia, have been commonly reported, complete heart block (CHB) necessitating a pacemaker is rare in EMF. Transvenous pacing is technically limited by fibrotic obliteration of the affected ventricle that results in poor lead parameters, and alternative pacing strategy like epicardial pacing may be required in many. We report three cases of EMF, who were treated with an alternative pacing strategy.
format Online
Article
Text
id pubmed-8414184
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-84141842021-09-08 A Novel pacing option in patients with endomyocardial fibrosis: A case series Sundaram, Chandrasekar Kartik S, Viswanatha Namboodiri, Narayanan Ajitkumar, Valaparambil K Indian Pacing Electrophysiol J Case Report Endomyocardial fibrosis (EMF) is characterized by fibrous tissue deposition on the endocardial surface leading to impaired filling of one or both ventricles, resulting in either right or left heart failure or both. Although Sinus node dysfunction and tachyarrhythmia - atrial fibrillation, ventricular tachycardia, have been commonly reported, complete heart block (CHB) necessitating a pacemaker is rare in EMF. Transvenous pacing is technically limited by fibrotic obliteration of the affected ventricle that results in poor lead parameters, and alternative pacing strategy like epicardial pacing may be required in many. We report three cases of EMF, who were treated with an alternative pacing strategy. Elsevier 2021-05-24 /pmc/articles/PMC8414184/ /pubmed/34044159 http://dx.doi.org/10.1016/j.ipej.2021.05.007 Text en © 2021 Indian Heart Rhythm Society. Production and hosting by Elsevier B.V. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Case Report
Sundaram, Chandrasekar
Kartik S, Viswanatha
Namboodiri, Narayanan
Ajitkumar, Valaparambil K
A Novel pacing option in patients with endomyocardial fibrosis: A case series
title A Novel pacing option in patients with endomyocardial fibrosis: A case series
title_full A Novel pacing option in patients with endomyocardial fibrosis: A case series
title_fullStr A Novel pacing option in patients with endomyocardial fibrosis: A case series
title_full_unstemmed A Novel pacing option in patients with endomyocardial fibrosis: A case series
title_short A Novel pacing option in patients with endomyocardial fibrosis: A case series
title_sort novel pacing option in patients with endomyocardial fibrosis: a case series
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8414184/
https://www.ncbi.nlm.nih.gov/pubmed/34044159
http://dx.doi.org/10.1016/j.ipej.2021.05.007
work_keys_str_mv AT sundaramchandrasekar anovelpacingoptioninpatientswithendomyocardialfibrosisacaseseries
AT kartiksviswanatha anovelpacingoptioninpatientswithendomyocardialfibrosisacaseseries
AT namboodirinarayanan anovelpacingoptioninpatientswithendomyocardialfibrosisacaseseries
AT ajitkumarvalaparambilk anovelpacingoptioninpatientswithendomyocardialfibrosisacaseseries
AT sundaramchandrasekar novelpacingoptioninpatientswithendomyocardialfibrosisacaseseries
AT kartiksviswanatha novelpacingoptioninpatientswithendomyocardialfibrosisacaseseries
AT namboodirinarayanan novelpacingoptioninpatientswithendomyocardialfibrosisacaseseries
AT ajitkumarvalaparambilk novelpacingoptioninpatientswithendomyocardialfibrosisacaseseries